Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread [11]

British Journal of Dermatology

Volumn 147, Issue 3, 2002, Pages 621-623

  Ugurel, Selma ^a   Wagner, A ^a   Pfohler C ^a   Tilgen, W ^a   Reinhold, U ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

AGED; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; AXILLARY LYMPH NODE; BIOLOGICAL MONITORING; BLOOD CELL COUNT; BLOOD CHEMISTRY; CASE REPORT; CONFIDENCE INTERVAL; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LETTER; LYMPH NODE METASTASIS; MALE; MELANOMA; PRIORITY JOURNAL; SKIN METASTASIS;

EID: 0036053251     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.488811.x     Document Type: Letter

References (9)

1. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
2. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine
3. Cytokine induction by the immunomodulators imiquimod and S-27609
4. Self-administered topical 5% imiquimod cream for external anogenital warts
5. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multi-center 6-week dose-response trial
6. Imiquimod 5% cream in the treatment of Bowen's disease
7. Imiquimod: A novel treatment for lentigo maligna
8. Topical imiquimod treatment of a cutaneous melanoma metastasis
9. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells